BioXcel Therapeutics Advances Process Development for BXCL501 Thin Film Formulation
Automated, scalable process developed for manufacturing clinical and commercial supply BXCL501 thin film architecture is proprietary and flexible for combination therapies Multiple subjects treated with BXCL501 in ascending dose Phase 1 clinical trial …